David L. Bourdet

City:

Millbrae, California

Country:

United States

Published Applications:

Last publication date:

2025-09-18

Top Assignees for applications by David L. Bourdet

The entities that hold a legal rights for patent applications filed by inventor Bourdet David L.:

THERAVANCE BIOPHARMA R&D IP, LLC 4 South San Francisco, CA United States

Recent patent applications by Bourdet David L.

David L. Bourdet from Millbrae, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-18

US20250288561A1

Human necessities

NEZULCITINIB FOR DELIVERY BY NEBULIZED ORAL INHALATION

#2 | 2024-10-03

US20240327360A1

Chemistry; metallurgy

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOLE-5-CARBOXAMIDO)-2-METHYLPENTANOIC ACID AND USES THEREOF

#3 | 2023-11-23

US20230372318A1

Human necessities

METHODS FOR TREATING A SUBJECT HAVING MULTIPLE SYSTEM ATROPHY

#4 | 2022-08-04

US20220242836A1

Chemistry; metallurgy

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof

#5 | 2019-01-03

US20190002416A1

Chemistry; metallurgy

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

#6 | 2017-09-28

US20170275259A1

Chemistry; metallurgy

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

InventorID:

1994247 ⎘